These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1778475)

  • 1. Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes.
    Knorre DG; Vlassov VV
    Genetica; 1991; 85(1):53-63. PubMed ID: 1778475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide derivatives as gene-targeted drugs.
    Knorre DG; Vlassov VV
    Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
    Tidd DM
    Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Active derivatives of oligonucleotides with a zwitterionic terminal phosphate group for design of affinity reagents and probes].
    Godovikova TS; Zarytova VF; Mal'tseva TV; Khalimskaia LM
    Bioorg Khim; 1989 Sep; 15(9):1246-52. PubMed ID: 2590253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactivity of oligonucleotide derivatives, containing a methylphosphate group. Affinity modification of target DNA by 4-N-(methyl-N-2-chlorethylamino)benzyl 3'- and 5'-phosphamide derivatives of octathymidylate containing methylphosphonate residues].
    Amirkhanov NV; Zarytova VF
    Bioorg Khim; 1989 Mar; 15(3):379-86. PubMed ID: 2742618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects.
    Knorre DG; Vlassov VV; Zarytova VF; Karpova GG
    Adv Enzyme Regul; 1985; 24():277-99. PubMed ID: 3915185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.
    Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV
    Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides as effectors of the sequence-specific modification of nucleic acids with reactive oligonucleotide derivatives.
    Kutyavin IV; Podyminogin MA; Bazhina YuN ; Fedorova OS; Knorre DG; Levina AS; Mamayev SV; Zarytova VF
    FEBS Lett; 1988 Sep; 238(1):35-8. PubMed ID: 3169251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene-directed biologically active substances (antisense oligonucleotides and their derivatives)].
    Knorre DG
    Bioorg Khim; 1997 Jan; 23(1):3-17. PubMed ID: 9139640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation.
    Noonberg SB; Scott GK; Garovoy MR; Benz CC; Hunt CA
    Nucleic Acids Res; 1994 Jul; 22(14):2830-6. PubMed ID: 8052538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific regulation of gene expression by antisense nucleic acids: a summary of methodologies and associated problems.
    Kawasaki H; Machida M; Komatsu M; Li HO; Murata T; Tsutsui H; Fujita A; Matsumura M; Kobayashi Y; Taira K; Yokoyama KK
    Artif Organs; 1996 Aug; 20(8):836-48. PubMed ID: 8853793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of RNA structure on antisense oligonucleotide hybridization kinetics.
    Lima WF; Monia BP; Ecker DJ; Freier SM
    Biochemistry; 1992 Dec; 31(48):12055-61. PubMed ID: 1280997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-O-alkyl oligoribonucleotides as antisense probes.
    Iribarren AM; Sproat BS; Neuner P; Sulston I; Ryder U; Lamond AI
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7747-51. PubMed ID: 2145581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the target structure on the efficiency of alkylation of single-stranded DNA with the reactive derivatives of antisense oligonucleotides.
    Fedorova OS; Podust LM; Maksakova GA; Gorn VV; Knorre DG
    FEBS Lett; 1992 May; 302(1):47-50. PubMed ID: 1587352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.
    Bielinska A; Kukowska-Latallo JF; Johnson J; Tomalia DA; Baker JR
    Nucleic Acids Res; 1996 Jun; 24(11):2176-82. PubMed ID: 8668551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of template on the human ribosome as revealed from data on cross-linking with reactive mRNA analogs.
    Graifer DM; Karpova GG; Knorre DG
    Biochemistry (Mosc); 2001 Jun; 66(6):585-602. PubMed ID: 11421806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNA-modified oligonucleotides are highly efficient as FISH probes.
    Silahtaroglu A; Pfundheller H; Koshkin A; Tommerup N; Kauppinen S
    Cytogenet Genome Res; 2004; 107(1-2):32-7. PubMed ID: 15305054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects.
    Vlassov VV; Godovikov AA; Kobetz ND; Ryte AS; Yurchenko LV; Bukrinskaya AG
    Adv Enzyme Regul; 1985; 24():301-20. PubMed ID: 3835822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.